Primary external auditory canal cholesteatoma in a young adult: Diagnostic challenges and surgical management of a rare otologic entity Authors: Abdelilah Rguyeg, Mohamed Boutahar, Azeddine Lachkar Published: 2026 ABSTRACT External auditory canal cholesteatoma is a rare and potentially destructive otologic condition characterized by the accumulation of keratinizing squamous epithelium within the external auditory canal, leading to progressive bony erosion. Despite being described in the 19th century, EACC remains an uncommon and frequently underrecognized entity, often misdiagnosed as keratosis obturans or chronic otitis externa. Its pathogenesis is multifactorial and incompletely understood, involving impaired epithelial migration, chronic microtrauma, local inflammation, and ischemic changes of the canal skin.Clinical presentation is usually nonspecific and includes otalgia, otorrhea, aural fullness, and conductive hearing loss, contributing to diagnostic delay. Otoscopic examination typically reveals keratin debris associated with focal bone exposure. High-resolution computed tomography of the temporal bone plays a key role in evaluating bony erosion and disease extent; however, it lacks specificity for definitive tissue characterization, and magnetic resonance imaging may be useful in selected cases for differential diagnosis.We report the case of a 25-year-old patient with no relevant medical history who presented with persistent unilateral otorrhea of 3 months’ duration, associated with severe otalgia and progressive hearing loss. A comprehensive clinical and radiological assessment suggested the diagnosis of primary external auditory canal cholesteatoma, which was subsequently confirmed by histopathological examination. The patient underwent surgical management with favorable clinical and functional outcomes.This case highlights the importance of a multidisciplinary diagnostic approach and early stage-adapted management to prevent complications and reduce the risk of recurrence. Introduction External auditory canal cholesteatoma (EACC) is a rare and potentially destructive otologic condition characterized by the accumulation of keratinizing squamous epithelium within the external auditory canal, leading to progressive focal or circumferential bony erosion. First described by Toynbee in the mid-19th century and later distinguished from keratosis obturans, EACC accounts for approximately 0.1%-0.5% of otologic diseases and remains an underrecognized clinical entity. Its rarity, coupled with nonspecific early symptoms, often results in delayed diagnosis and inappropriate initial management [1]. The pathogenesis of EACC is multifactorial and incompletely understood. Proposed mechanisms include impaired epithelial migration, chronic microtrauma, local inflammation, ischemic changes of the canal skin, and altered microcirculation. EACC may occur as a primary (idiopathic) form or secondary to predisposing factors such as external auditory canal stenosis, prior otologic surgery, trauma, radiotherapy, or chronic otitis externa. Clinically, patients typically present with otalgia, otorrhea, aural fullness, and conductive or mixed hearing loss, while otoscopic examination may reveal keratin debris associated with focal bone exposure [2]. Imaging plays a central role in the diagnostic workup of EACC. High-resolution computed tomography (HRCT) of the temporal bone is essential for evaluating the extent of bony erosion, lesion localization, and possible extension to adjacent structures. However, HRCT lacks specificity for tissue characterization and cannot reliably distinguish cholesteatoma from other soft tissue lesions of the external auditory canal. Magnetic resonance imaging (MRI), particularly diffusion-weighted imaging (DWI), may provide additional value in selected cases by improving lesion characterization and aiding in differential diagnosis, especially when atypical features are present. Several clinical and radiological staging systems have been proposed to guide management and predict disease severity. Therapeutic strategies range from conservative local debridement and close surveillance in early-stage disease to surgical intervention, most commonly canaloplasty with or without reconstruction, in advanced cases. Early recognition and stage-adapted management are crucial to prevent complications, reduce recurrence rates, and optimize long-term clinical outcomes [3]. Case presentation We report the case of a 25-year-old patient with no history of recurrent childhood otitis media or habitual water exposure, and no significant personal or family medical history. The patient presented with foul-smelling right-sided otorrhea of 3 months’ duration, with a gradual onset and a progressive increase in volume. The predominant symptom was severe, sleep-disturbing right-sided otalgia, occurring spontaneously and exacerbated by minimal mechanical stimuli such as mastication. The patient also complained of ipsilateral hearing loss, with no history of preceding local trauma. No associated systemic symptoms were reported, including fever, night sweats, weight loss, asthenia, or easy bruising, and clinical evaluation revealed no features suggestive of an underlying systemic disease. Otoscopic examination of the right ear revealed an accumulation of keratinous debris occupying the external auditory canal, associated with localized areas of exposed underlying bone and inflammatory changes of the canal skin, including erythema and friability. The lesion appeared adherent to the canal wall, limiting complete visualization of the medial canal. The tympanic membrane was only partially visualized, yet the visible portions appeared intact, without perforation, retraction, or signs of middle ear inflammation (Fig. 1).Fig. 1Otoscopic view of the right external auditory canal demonstrating accumulation of keratinous debris adherent to the canal wall, associated with localized inflammatory changes of the canal skin, including erythema and friability. Focal areas of exposed underlying bone are noted, consistent with an erosive process involving the external auditory canal.Fig 1 dummy alt text Otoscopic view of the right external auditory canal demonstrating accumulation of keratinous debris adherent to the canal wall, associated with localized inflammatory changes of the canal skin, including erythema and friability. Focal areas of exposed underlying bone are noted, consistent with an erosive process involving the external auditory canal. Audiological evaluation, including pure-tone audiometry, demonstrated a conductive hearing loss on the affected side, consistent with obstruction and inflammatory involvement of the external auditory canal, while contralateral hearing thresholds were within normal limits. Laboratory investigations, including a complete blood count and inflammatory markers, were within normal limits, with a white blood cell count of 7.8 × 10⁹/L and a C-reactive protein level of 2.1 mg/L, indicating the absence of systemic infection, inflammatory disease, or immunological dysfunction. An auricular swab specimen was obtained from the right external auditory canal for cytobacteriological examination and antibiotic susceptibility testing. Microbiological analysis revealed commensal cutaneous flora without isolation of specific pathogenic organisms, a finding consistent with the known microbiological profile of external auditory canal cholesteatoma, in which bacterial colonization is often secondary and not the primary pathogenic mechanism. The absence of significant pathogenic growth further supported the diagnosis of a keratinizing epithelial process rather than an infectious otitis externa. High-resolution computed tomography of the right temporal bone, obtained in axial and coronal planes, demonstrated a soft-tissue density lesion confined to the external auditory canal, associated with focal erosion of the bony canal wall, without evidence of extension to the middle ear cavity, mastoid air cells, or adjacent critical structures (Fig. 2, Fig. 3).Fig. 2High-resolution computed tomography (HRCT) of the right temporal bone, axial plane, showing a soft-tissue density lesion within the external auditory canal (arrow), associated with focal erosion of the adjacent bony canal wall. No extension to the middle ear cavity, mastoid air cells, or adjacent critical structures is identified.Fig 2 dummy alt textFig. 3Coronal HRCT image of the right temporal bone demonstrating a localized soft-tissue lesion within the external auditory canal (arrow), with associated focal bony erosion. The tympanic cavity and mastoid air cell system are preserved, with no evidence of medial or posterior extension.Fig 3 dummy alt text High-resolution computed tomography (HRCT) of the right temporal bone, axial plane, showing a soft-tissue density lesion within the external auditory canal (arrow), associated with focal erosion of the adjacent bony canal wall. No extension to the middle ear cavity, mastoid air cells, or adjacent critical structures is identified. Coronal HRCT image of the right temporal bone demonstrating a localized soft-tissue lesion within the external auditory canal (arrow), with associated focal bony erosion. The tympanic cavity and mastoid air cell system are preserved, with no evidence of medial or posterior extension. Magnetic resonance imaging (MRI) of the temporal bone was subsequently performed to further characterize the lesion. Diffusion-weighted imaging (DWI) demonstrated a well-defined hyperintense lesion within the external auditory canal (Fig. 4), consistent with diffusion restriction. These imaging findings are highly suggestive of cholesteatoma. No significant enhancement was observed on contrast-enhanced sequences, arguing against inflammatory or neoplastic lesions.Fig. 4Magnetic resonance imaging (MRI) of the right temporal bone. Diffusion-weighted imaging (DWI) demonstrates a well-defined hyperintense lesion within the external auditory canal (arrow), consistent with diffusion restriction, a characteristic feature suggestive of cholesteatoma. No extension to adjacent structures is observed.Fig 4 dummy alt text Magnetic resonance imaging (MRI) of the right temporal bone. Diffusion-weighted imaging (DWI) demonstrates a well-defined hyperintense lesion within the external auditory canal (arrow), consistent with diffusion restriction, a characteristic feature suggestive of cholesteatoma. No extension to adjacent structures is observed. Based on the integration of clinical presentation, otoscopic findings, and characteristic HRCT features, the diagnosis of primary external auditory canal cholesteatoma was strongly suggested. The patient subsequently underwent surgical treatment, consisting of complete excision of the cholesteatoma followed by canaloplasty to restore the normal anatomy of the external auditory canal (Fig. 5, Fig. 6). Histopathological examination of the excised specimen confirmed the diagnosis by demonstrating keratinizing stratified squamous epithelium with lamellated keratin debris, consistent with external auditory canal cholesteatoma.Fig. 5Intraoperative endoscopic view of the right external auditory canal during surgical management, demonstrating dissection and removal of the cholesteatoma matrix. Keratin debris and inflammatory tissue are observed adherent to areas of eroded canal bone, confirming the locally destructive nature of the lesion.Fig 5 dummy alt textFig. 6Intraoperative endoscopic view following complete excision of the cholesteatoma, illustrating the canaloplasty stage. The bony canal walls have been smoothed and widened to restore normal canal anatomy and facilitate physiological epithelial migration.Fig 6 dummy alt text Intraoperative endoscopic view of the right external auditory canal during surgical management, demonstrating dissection and removal of the cholesteatoma matrix. Keratin debris and inflammatory tissue are observed adherent to areas of eroded canal bone, confirming the locally destructive nature of the lesion. Intraoperative endoscopic view following complete excision of the cholesteatoma, illustrating the canaloplasty stage. The bony canal walls have been smoothed and widened to restore normal canal anatomy and facilitate physiological epithelial migration. The postoperative course was uneventful, with complete resolution of otalgia and otorrhea and progressive improvement in hearing. No evidence of residual or recurrent disease was observed during clinical and radiological follow-up. Discussion External auditory canal cholesteatoma (EACC) is a rare otologic entity, representing approximately 0.1–0.5% of otologic diseases encountered in outpatient practice. First described by Toynbee in 1850 and later distinguished from keratosis obturans, EACC is characterized by keratinizing squamous epithelium associated with progressive focal or circumferential bony erosion of the external auditory canal. Although traditionally considered a disease of middle-aged and elderly patients, recent series have demonstrated that EACC may occur across a wide age spectrum, including young adults, as illustrated in the present case. A slight female predominance and unilateral involvement are frequently reported in the literature [4]. The exact pathophysiological mechanisms underlying EACC remain incompletely understood and are likely multifactorial. Proposed mechanisms include impaired epithelial migration, chronic microtrauma of the canal skin, localized ischemia, chronic inflammation, and altered microcirculation of the periosteum. Primary (idiopathic) EACC arises in the absence of identifiable predisposing factors, whereas secondary forms are associated with external auditory canal stenosis, prior otologic surgery, trauma, radiotherapy, or chronic otitis externa. Progressive accumulation of keratin debris leads to pressure necrosis and osteitis, resulting in focal bone erosion and potential extension to adjacent structures [5]. The clinical diagnosis of EACC is often challenging due to the nonspecific nature of its presentation and its overlap with other external ear pathologies. Patients commonly present with progressive otalgia, chronic or recurrent otorrhea, aural fullness, and conductive or mixed hearing loss. Otoscopic examination remains the cornerstone of initial evaluation, typically demonstrating keratinous debris adherent to the canal wall, frequently associated with focal bone exposure and localized inflammatory changes. Visualization of the tympanic membrane may be limited but is usually preserved in primary forms without medial extension. Imaging plays a central role in the diagnostic workup and staging of EACC. High-resolution computed tomography (HRCT) of the temporal bone is the imaging modality of choice for assessing the extent of bony erosion, lesion localization, and potential involvement of adjacent structures, including the tympanic cavity, mastoid air cells, facial nerve canal, temporomandibular joint, and dura mater. However, HRCT lacks specificity for tissue characterization and cannot reliably distinguish cholesteatoma from other soft tissue lesions of the external auditory canal. Magnetic resonance imaging (MRI), particularly diffusion-weighted imaging (DWI), plays a pivotal complementary role in selected cases. Cholesteatoma typically demonstrates marked hyperintensity on DWI due to true restriction of diffusion. However, this feature is not entirely specific, as abscesses may also exhibit diffusion restriction, representing a potential diagnostic pitfall. In such situations, contrast-enhanced MRI is of particular value, as cholesteatoma typically shows no enhancement, whereas inflammatory, infectious, or neoplastic lesions demonstrate variable enhancement patterns. Therefore, the combination of HRCT and MRI provides a more comprehensive assessment and improves diagnostic confidence, especially in atypical or equivocal cases. The differential diagnosis of EACC is broad and includes keratosis obturans, necrotizing (malignant) otitis externa, chronic otitis externa, external auditory canal neoplasms, abscess, and, less commonly, Langerhans cell histiocytosis. Keratosis obturans is typically bilateral and characterized by circumferential canal widening without focal bony erosion. Necrotizing otitis externa usually affects immunocompromised or diabetic patients and is associated with severe pain, granulation tissue, and skull base involvement. Granulation tissue and inflammatory lesions typically demonstrate enhancement on contrast-enhanced MRI. Abscesses may show diffusion restriction but are usually associated with peripheral enhancement. Malignant lesions often present as irregular masses with aggressive bone destruction and significant enhancement. Accurate differentiation is crucial, as management strategies and prognostic implications differ significantly [6]. Audiological evaluation typically demonstrates conductive hearing loss, although mixed patterns may be observed in advanced stages. Laboratory investigations are generally nonspecific and are mainly useful to exclude systemic infection or inflammatory disease. Histopathological examination remains the gold standard for definitive diagnosis, demonstrating keratinizing stratified squamous epithelium with lamellated keratin debris, as observed in the present case [7]. Management of EACC is guided by disease stage, symptom severity, and extent of bony involvement. Early-stage disease without significant erosion may be managed conservatively with regular debridement and close follow-up. However, surgical intervention is indicated in symptomatic or advanced cases, particularly in the presence of bony erosion or disease progression. Canaloplasty with complete excision of the cholesteatoma matrix remains the cornerstone of surgical management, with reconstruction performed as needed to restore normal epithelial migration. Stage-adapted approaches, as proposed by clinical–radiological classifications such as those of Shin and Udayabhanu, have been shown to optimize outcomes and reduce morbidity [8]. When appropriately diagnosed and treated, the prognosis of EACC is generally favorable, with resolution of symptoms and improvement or stabilization of hearing. Recurrence rates are relatively low but remain possible, particularly in cases of incomplete excision or advanced disease, highlighting the importance of long-term follow-up [9]. One limitation of this report is the absence of magnetic resonance imaging, which could have provided additional information for tissue characterization and differential diagnosis. Nevertheless, the diagnosis in this case was strongly supported by the clinical presentation and HRCT findings and was definitively confirmed by histopathological examination. Although rare, EACC is a potentially destructive condition that requires a high index of suspicion and a multidisciplinary diagnostic approach. The present case highlights that EACC can occur in young patients without identifiable risk factors and underscores the importance of integrating clinical, radiological, and histopathological data to ensure accurate diagnosis and appropriate management [10]. Conclusion External auditory canal cholesteatoma is a rare but potentially destructive otologic condition that requires a high index of suspicion and a multidisciplinary diagnostic approach. While high-resolution computed tomography is essential for evaluating the extent of bony involvement and guiding management, it is not sufficient for definitive diagnosis and should be complemented by magnetic resonance imaging in selected cases to improve lesion characterization and differential diagnosis. Histopathological examination remains the gold standard for confirming the diagnosis. Early recognition and appropriate stage-adapted management—most often surgical—are essential to prevent disease progression and complications. When adequately treated, clinical outcomes are generally favorable; however, long-term follow-up remains necessary due to the risk of recurrence. Patient consent Complete written informed consent was obtained from the patient for the publication of this study and accompanying images.